Tetragon Financial
Group Limited March 2022 Monthly
Factsheet
LONDON, April 29, 2022 -- Tetragon has released its
Monthly Factsheet for March 2022.
- Net Asset Value: $2,797m
- Fully Diluted NAV Per Share: $28.88
- Share Price (TFG NA): $9.06
- Monthly NAV per share total return: 0.0%
- Monthly Return on Equity: 0.6%
- Most recent quarterly dividend: $0.11
- Dividend yield: 4.6%
Please refer to important disclosures
on page 5 of the Monthly Factsheet.
Please click below to access the Monthly Factsheet.
March 2022 Factsheet
About Tetragon:
Tetragon is a closed-ended investment company that invests in a
broad range of assets, including public and private equities and
credit (including distressed securities and structured credit),
convertible bonds, real estate, venture capital, infrastructure,
bank loans and TFG Asset Management, a diversified alternative
asset management business. Where appropriate, through TFG Asset
Management, Tetragon seeks to own all, or a portion, of asset
management companies with which it invests in order to enhance the
returns achieved on its capital. Tetragon's investment objective is
to generate distributable income and capital appreciation. It aims
to provide stable returns to investors across various credit,
equity, interest rate, inflation and real estate cycles. The
company's non-voting shares are traded on Euronext in Amsterdam, a regulated market of Euronext
Amsterdam N.V., and on the Specialist Fund Segment of the main
market of the London Stock Exchange. For more information please
visit the company's website at www.tetragoninv.com.
Tetragon:
Yuko Thomas
Investor Relations
ir@tetragoninv.com |
Press Inquiries:
Prosek Partners
Pro-tetragon@prosek.com
United States
Ryan FitzGibbon Remy
Marin
+1 646 818 9298 +1 646 818
9234 |
United Kingdom
Henrietta
Dehn
Alexa Bethell
+44 7717 281 665 +44 7940 166
251 |
This release does not contain or constitute an
offer to sell or a solicitation of an offer to purchase
securities in the United States or any other
jurisdiction. The securities of Tetragon have not been and will not
be registered under the U.S. Securities Act of 1933 and may not be
offered or sold in the United
States or to U.S. persons unless they are registered under
applicable law or exempt from registration. Tetragon does not
intend to register any portion of its securities in the United States or to conduct a public offer
of securities in the United
States. In addition, Tetragon has not been and will not be
registered under the U.S. Investment Company Act of 1940, and
investors will not be entitled to the benefits of such Act.
Tetragon is registered in the public register of the Netherlands
Authority for the Financial Markets under Section 1:107 of the
Financial Markets Supervision Act as a collective investment scheme
from a designated country.